$6.66
-0.1399[-2.06%]
At close: Apr 24
$6.66
0[0.00%]
After Hours: 4:29PM EDT
Telomir Pharmaceuticals
(NASDAQ:TELO)Telomir Pharmaceuticals Stock (NASDAQ:TELO), Quotes and News Summary
Telomir Pharmaceuticals Stock (NASDAQ: TELO) stock price, news, charts, stock research, profile.
| Open | $6.770 |
| Close | $6.865 |
| Volume / Avg. | 23.964K / 72.730K |
| Day Range | 5.900 - 6.865 |
| 52 Wk Range | 4.760 - 20.720 |
| Market Cap | $197.201M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 49 |
| Short Interest | 0.09% |
| Days to Cover | 1 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Telomir Pharmaceuticals Inc
Sector
Health Care
Industry
Pharmaceuticals
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the developmen...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Telomir Pharmaceuticals (TELO) stock?
You can purchase shares of Telomir Pharmaceuticals (NASDAQ: TELO) through any online brokerage.
Who are Telomir Pharmaceuticals's (TELO) competitors?
Other companies in Telomir Pharmaceuticals’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Xeris Biopharma Holdings (NASDAQ:XERS), Terns Pharma (NASDAQ:TERN) and Rani Therapeutics Hldgs (NASDAQ:RANI).
What is the target price for Telomir Pharmaceuticals (TELO) stock?
There is no analysis for Telomir Pharmaceuticals.
Current Stock Price for Telomir Pharmaceuticals (TELO)?
The stock price for Telomir Pharmaceuticals (NASDAQ: TELO) is $6.66 last updated April 24, 2024 at 4:29 PM EDT.
Does Telomir Pharmaceuticals (TELO) pay a dividend?
There are no upcoming dividends for Telomir Pharmaceuticals.
When is Telomir Pharmaceuticals (NASDAQ:TELO) reporting earnings?
Telomir Pharmaceuticals’s Q1 earnings are confirmed for Sunday, May 12, 2024.
Is Telomir Pharmaceuticals (TELO) going to split?
There is no upcoming split for Telomir Pharmaceuticals.
What sector and industry does Telomir Pharmaceuticals (TELO) operate in?
Telomir Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.